256 related articles for article (PubMed ID: 32770257)
1. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
[TBL] [Abstract][Full Text] [Related]
2. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
[TBL] [Abstract][Full Text] [Related]
3. The Novel Atypical Dopamine Uptake Inhibitor
Rotolo RA; Dragacevic V; Kalaba P; Urban E; Zehl M; Roller A; Wackerlig J; Langer T; Pistis M; De Luca MA; Caria F; Schwartz R; Presby RE; Yang JH; Samels S; Correa M; Lubec G; Salamone JD
Front Pharmacol; 2019; 10():682. PubMed ID: 31316379
[TBL] [Abstract][Full Text] [Related]
4. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
[TBL] [Abstract][Full Text] [Related]
5. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions.
Yohn SE; Reynolds S; Tripodi G; Correa M; Salamone JD
Behav Brain Res; 2018 Apr; 342():27-34. PubMed ID: 29292157
[TBL] [Abstract][Full Text] [Related]
6. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.
Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD
Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556
[TBL] [Abstract][Full Text] [Related]
7. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
[TBL] [Abstract][Full Text] [Related]
8. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD
PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131
[TBL] [Abstract][Full Text] [Related]
9. A Novel and Selective Dopamine Transporter Inhibitor,
Kouhnavardi S; Ecevitoglu A; Dragačević V; Sanna F; Arias-Sandoval E; Kalaba P; Kirchhofer M; Lubec J; Niello M; Holy M; Zehl M; Pillwein M; Wackerlig J; Murau R; Mohrmann A; Beard KR; Sitte HH; Urban E; Sagheddu C; Pistis M; Plasenzotti R; Salamone JD; Langer T; Lubec G; Monje FJ
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883437
[TBL] [Abstract][Full Text] [Related]
10. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.
Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584
[TBL] [Abstract][Full Text] [Related]
11. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
Contreras-Mora H; Rowland MA; Yohn SE; Correa M; Salamone JD
Pharmacol Biochem Behav; 2018 Mar; 166():13-20. PubMed ID: 29309800
[TBL] [Abstract][Full Text] [Related]
12. Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.
Yohn SE; Lopez-Cruz L; Hutson PH; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Mar; 233(6):949-60. PubMed ID: 26694811
[TBL] [Abstract][Full Text] [Related]
13. The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats.
Sommer S; Danysz W; Russ H; Valastro B; Flik G; Hauber W
Int J Neuropsychopharmacol; 2014 Dec; 17(12):2045-56. PubMed ID: 24964269
[TBL] [Abstract][Full Text] [Related]
14. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists.
Yohn SE; Santerre JL; Nunes EJ; Kozak R; Podurgiel SJ; Correa M; Salamone JD
Pharmacol Biochem Behav; 2015 Aug; 135():217-26. PubMed ID: 26022661
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040.
Yohn SE; Gogoj A; Haque A; Lopez-Cruz L; Haley A; Huxley P; Baskin P; Correa M; Salamone JD
Pharmacol Biochem Behav; 2016 Sep; 148():84-91. PubMed ID: 27296079
[No Abstract] [Full Text] [Related]
16. Structure-Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters.
Kalaba P; Ilić M; Aher NY; Dragačević V; Wieder M; Zehl M; Wackerlig J; Beyl S; Sartori SB; Ebner K; Roller A; Lukic N; Beryozkina T; Gonzalez ERP; Neill P; Khan JA; Bakulev V; Leban JJ; Hering S; Pifl C; Singewald N; Lubec J; Urban E; Sitte HH; Langer T; Lubec G
J Med Chem; 2020 Jan; 63(1):391-417. PubMed ID: 31841637
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors.
Ecevitoglu A; Meka N; Rotolo RA; Edelstein GA; Srinath S; Beard KR; Carratala-Ros C; Presby RE; Cao J; Okorom A; Newman AH; Correa M; Salamone JD
Neuropsychopharmacology; 2024 Mar; ():. PubMed ID: 38429498
[TBL] [Abstract][Full Text] [Related]
18. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D1 receptors in the medial orbitofrontal cortex support effort-related responding in rats.
Münster A; Sommer S; Hauber W
Eur Neuropsychopharmacol; 2020 Mar; 32():136-141. PubMed ID: 32029310
[TBL] [Abstract][Full Text] [Related]
20. Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression.
Yohn SE; Gorka D; Mistry A; Collins S; Qian E; Correa M; Manchanda A; Bogner RH; Salamone JD
J Nat Prod; 2017 Oct; 80(10):2839-2844. PubMed ID: 28905625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
